Hybrid and vaccine‐induced immunity against SAR‐CoV‐2 in MS patients on different disease‐modifying therapies

OBJECTIVE: To compare “hybrid immunity” (prior COVID‐19 infection plus vaccination) and post‐vaccination immunity to SARS CoV‐2 in MS patients on different disease‐modifying therapies (DMTs) and to assess the impact of vaccine product and race/ethnicity on post‐vaccination immune responses. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Kister, Ilya, Curtin, Ryan, Pei, Jinglan, Perdomo, Katherine, Bacon, Tamar E., Voloshyna, Iryna, Kim, Joseph, Tardio, Ethan, Velmurugu, Yogambigai, Nyovanie, Samantha, Valeria Calderon, Andrea, Dibba, Fatoumatta, Stanzin, Igda, Samanovic, Marie I., Raut, Pranil, Raposo, Catarina, Priest, Jessica, Cabatingan, Mark, Winger, Ryan C., Mulligan, Mark J., Patskovsky, Yury, Silverman, Gregg J., Krogsgaard, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538694/
https://www.ncbi.nlm.nih.gov/pubmed/36165097
http://dx.doi.org/10.1002/acn3.51664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538694/
https://www.ncbi.nlm.nih.gov/pubmed/36165097
http://dx.doi.org/10.1002/acn3.51664

Ejemplares similares